Lyra Therapeutics, Inc. Proclaims Goal to Voluntarily Record Shape 25 for Delisting from Nasdaq and Next Deregistration with the SEC
WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the…
Virtual Asset Applied sciences Inc. Pronounces Purpose to Amend and Refile Monetary Statements and MD&A
VANCOUVER, BC, April 10, 2026 (GLOBE NEWSWIRE) -- Virtual Asset Applied sciences…
